CEO - OPKO Renal Division which is Rayaldy
President - OPKO Diagnostics which is 4k score.
You might be right, and of course Bryan says things without even looking at the chart. After hitting a high in March, opko trended down until it hit the most recent low 6.14 the day after Jefferies conference on June 5th. It has been up and hitting new highs ever since that conference. Opko has exited 4 of the next five months higher. I am not saying Jefferies had that much of a impact, but opko ended June at 7.10, but the week of Jefferies, when shorts got giddy Opko hit 6.14, The best buy or cover price of since. Hopefully OPPY starts the the next 5.point move, lol, one never knows.
SCIENCE. You can all say I am wrong, but brain tumor surgery does have a cure rate. YES a REAL cure rate. In the NWBO study, only 20 people, the DCVAC-L might have had NO impact at all. The variables in a study that small given a degree of cure by surgery, with no treatment might yield the same results, it is an unanswered question. Yes if you walk out after a Phase 3 you might say OMG, the luck, the luck might have been the skill of your surgeon, or the TYPE of tumor not the phase 3 at all.
The direct study answers a ton of questions, and see, if dcvax brain was a real vax, no one dies. I am long for now, and out a dinner parties worth, but the more I look, the questioner I get. If it is a vax that really works, not one patient should die.
I think they R on the right track, I think, OPK owns a license where you strip a protein from the shell creating a vax that covers every single possible mutation that cancer can make. I think by the time the vax is injected, a single mutation is a death sentence. Opk has the key to stop that, hope they meet up and hold hands.
I believe cancer can be cured in a two year window if all holding keys unlock doors together, court anyone, he took my key, or door #$%$, or key hole, OMY
genius but sly, OMG, do not forget to cover your short, depends, no I mean you can buy depends, it is a calculated move.
Yes Ron, I basically stop by now, board is trash, but will still throw a thought out there, unfortunately no one has posted here since SEPT, if you look at the dates of the posts. Fewer and fewer new posts, most all ignore yahoo boards.
U still on earnings, lol, I guess u missed the notice where OPKO closed down .02, big win for you, and in my .10 range, oh, we are above that range now. Day of earnings close 10.29, the pressure later that week was bozo the clown, u r so clueless.
From my perch I have been dead on as far as opk, and from my perch you have been, well you know, lol, we all know, lololol.
a perfect match. Bryan repeats himself, robo guy reposts others, lol, match made in paradise.
Yes on the technology, but I find the more I look at the company and the technology I come away with more questions than answers. As far as a downside gap, I see none, but we could retrace all of the Nov 11TH move, but though possible, I would not bank on it.
guess that will not help the share price.
Was grossly over bought, in oversold territory now, but does not mean it is done. Like to see a move on volume, any number is likely, lol, so 4.10 sounds fine to me. Basically it is giving up the spike on Nov 11 th.
Like to see it turn up on some late day volume, closing above 4.35 would be nice, if not we could test 4.00, then 3.80, SO that is one heck of a range, but likely stop offs. We will see shortly. Anything above 4.35 at the close is good.
I believe Prolar did a few webcasts, it said senior management to present, so likely not Frost. Betting it is the prolar guy, and the cytochroma guy, with a dash of 4k. Maybe 4k enrollment preliminary data, let the guessing begin, lol.
Wow, OPKO dooing a web cast, TOO, OMG. 10:55 am webcast can be accessed through OPKO investor relations.
not a cure, but a vaccine.
The funds control share price, period. Granted bogus SA can move a stock for a few minutes helping the author bail on their positions, but in the big picture, retail is nothing, yahoo boards entertainment, and those bashing or cheer leading well it is their time to waste. The most entertaining are those posts bashing in the name of helping other less knowledgeable investors, lol. Oh, and they never have an ax to grind, and usually no position, true humanitarians.
Some are questioning her prior career choices, I have decided to not bother with that thread again, it was a mistake to encourage that noise. I am looking at the technology, and that data that has been made available. If these follow up studies duplicate the earlier studies, I have no concerns about having a position here. There will be info before or no later than Feb on preliminary direct data, if it is good, any still short are in for a surprise. I can only lose 4.50 a share, lol. Not sure their potential lose?